NCT04283292View on ClinicalTrials.gov

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

March 18, 2022

Study Completion Date

March 18, 2022

Conditions
Cannabinoid Hyperemesis Syndrome
Interventions
DRUG

Capsaicin

Topical Capsaicin for the treatment of Cannabinoid Hyperemesis Syndrome

DRUG

Placebo

Placebo cream that is applied once topically

Trial Locations (1)

22908

UVA Health System, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT04283292 - Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome | Biotech Hunter | Biotech Hunter